You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for amino acids; magnesium chloride; potassium phosphate, dibasic; sodium chloride and what is the scope of patent protection?

Amino acids; magnesium chloride; potassium phosphate, dibasic; sodium chloride is the generic ingredient in two branded drugs marketed by Icu Medical Inc and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

Summary for AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE
Recent Clinical Trials for AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Nextrast, Inc.PHASE1
Mario Negri Institute for Pharmacological ResearchPHASE3
French Innovative Leukemia OrganisationPHASE2

See all AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE clinical trials

US Patents and Regulatory Information for AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Icu Medical Inc AMINOSYN 8.5% W/ ELECTROLYTES amino acids; magnesium chloride; potassium phosphate, dibasic; sodium chloride INJECTABLE;INJECTION 017673-005 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Icu Medical Inc AMINOSYN 7% W/ ELECTROLYTES amino acids; magnesium chloride; potassium phosphate, dibasic; sodium chloride INJECTABLE;INJECTION 017789-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for Amino Acids, Magnesium Chloride, Potassium Phosphate Dibasic, and Sodium Chloride

Last updated: July 30, 2025

Introduction

The global pharmaceutical landscape witnesses continuous evolution driven by demand for essential compounds like amino acids, mineral salts such as magnesium chloride, potassium phosphate dibasic, and sodium chloride. These compounds underpin numerous therapeutic, nutritional, and industrial applications, influencing market dynamics and financial trajectories. This analysis provides a comprehensive overview of current trends, demand drivers, competitive landscapes, and future outlooks for these key pharmaceutical ingredients.

Market Overview

Amino Acids

Amino acids are organic compounds fundamental for protein synthesis, with applications spanning pharmaceuticals, dietary supplements, and clinical nutrition. The global amino acids market is projected to reach approximately USD 4–5 billion by 2025, growing at a CAGR of 6–8% (Market Research Future). The primary drivers include increasing prevalence of malnutrition, rising interest in plant-based diets, and expanding biomedical research.

Magnesium Chloride

Magnesium chloride serves as a mineral supplement, electrolyte replenisher, and excipient in pharmaceuticals. The market is bolstered by rising cases of magnesium deficiency and its use in cold compresses and dermatological products. The global magnesium chloride market is anticipated to grow at a CAGR of around 4–6%, with an estimated valuation of USD 1.2 billion by 2025.

Potassium Phosphate Dibasic (Dibasic Potassium Phosphate)

This inorganic compound primarily functions as a phosphate supplement and pH buffer in intravenous solutions and enriched nutrition formulations. The market’s growth mirrors the expanding clinical nutrition sector and the shift toward parenteral nutrition, with a projected CAGR of approximately 5–7%.

Sodium Chloride

Sodium chloride (common salt) remains vital in intravenous therapy, electrolyte balance, and pharmaceutical excipients. The market benefits from consistent demand due to its widespread acceptance in healthcare. Its growth rate is stable, with projections indicating steady expansion driven by hospital procurement and manufacturing.

Market Dynamics

Demand Drivers

  • Rising Chronic Disease Burden: Increasing incidence of cardiovascular, neurological, and metabolic disorders heightens demand for electrolyte replenishment and nutritional support, propelling amino acids and mineral-based compounds.

  • Aging Population: Elderly demographics require targeted nutritional and pharmaceutical products, enhancing the need for amino acids, magnesium, potassium, and sodium-based formulations.

  • Health & Wellness Trends: The surge in health-conscious consumers promotes the consumption of supplements containing amino acids and mineral salts.

  • Clinical and Parenteral Nutrition: The expanding scope of injectable nutrition solutions amplifies demand, especially for potassium phosphate dibasic and sodium chloride.

Supply Chain and Raw Material Considerations

The supply of these compounds often hinges on raw material availability, environmental regulations, and manufacturing costs. For example, amino acid production depends on fermentation processes, which are sensitive to bio-reactor capacity and feedstock costs. Similarly, mineral salts like magnesium chloride rely on natural brine sources, with geopolitical factors influencing supply stability.

Competitive Landscape

Major players include Ajinomoto Co., Inc., Evonik Industries, Cargill, K+S Aktiengesellschaft, and regional manufacturers in China, India, and Europe. Market concentration remains moderate, with innovation in production techniques and quality standards serving as competitive differentiators.

Regulatory Environment

Stringent regulatory approval processes influence market entry and expansion strategies. For instance, amino acids classified as Generally Recognized as Safe (GRAS) by the FDA facilitate easier market access, whereas novel mineral formulations require comprehensive safety data.

Financial Trajectory Insights

Revenue Trends

The combined market value for these ingredients is expected to grow at a compounded rate of approximately 5–7% over the next five years. The amino acids sector is poised for the highest growth, driven by bioavailability improvements and new applications in personalized medicine.

Investment Opportunities

  • R&D Focus: Investment in sustainable fermentation technologies for amino acids and eco-friendly mineral extraction methods can foster growth.

  • Vertical Integration: Companies controlling raw material sources (e.g., brine extraction) can better manage costs and ensure supply chain resilience.

  • Product Innovation: Developing specialty formulations with enhanced bioavailability increases market competitiveness and profit margins.

Risks and Challenges

  • Regulatory Compliance: Keeping pace with evolving global standards demands significant investment.

  • Price Volatility: Raw material fluctuations impact profitability, especially in mineral-based compounds.

  • Market Saturation: Mature segments necessitate differentiation through quality, certification, and application diversification.

Future Outlook

The outlook for amino acids and mineral salts remains optimistic, fueled by technological advances, expanding clinical applications, and heightened health awareness. The Asia-Pacific region, led by China and India, will continue to dominate supply chains owing to lower manufacturing costs and burgeoning domestic demand.

Emerging trends include:

  • Customized Nutrition: Tailored amino acid blends and mineral formulations for personalized healthcare.

  • Sustainability Initiatives: Eco-conscious production reducing carbon footprint and waste, attracting environmentally aware investors.

  • Digital Supply Chain Optimization: Leveraging AI and IoT to enhance traceability and efficiency.

Key Market Trends

  • Increasing integration of amino acids into novel drug delivery systems, such as peptide therapeutics.
  • Explosive growth in mineral supplement use amidst rising magnesium deficiency awareness.
  • Growing use of potassium phosphate dibasic as a key component in ABC (Artificial Blood Component) and other advanced medical formulations.
  • Steady demand steadied by institutional procurement policies for sodium chloride solutions in hospitals.

Conclusion

The market landscape for amino acids, magnesium chloride, potassium phosphate dibasic, and sodium chloride exhibits strong growth prospects rooted in healthcare demand, nutritional trends, and technological innovations. Companies investing strategically in R&D, sustainable sourcing, and regulatory compliance are positioned to capitalize on expanding clinical and industrial applications, ensuring favorable financial trajectories.


Key Takeaways

  • Robust Growth: The combined market for these compounds is projected to grow at a CAGR of around 5–8%, driven heavily by clinical nutrition and health supplement demand.
  • Regionally Dominant Markets: Asia-Pacific continues to lead production and consumption, with investment opportunities in manufacturing expansion and sustainable practices.
  • Innovation & Differentiation: Advancements in bioavailability, formulation, and eco-friendly production will serve as key competitive advantages.
  • Regulatory Strategy: Staying ahead of global regulatory standards minimizes risk and accelerates product approval.
  • Supply Resilience: Vertical integration and diversification of raw material sources help mitigate supply chain disruptions and price volatility.

FAQs

1. How will emerging health trends influence the demand for amino acids?
Growing awareness around personalized nutrition and functional foods will increase demand for amino acids tailored for specific health needs, especially in sports nutrition, clinical nutrition, and metabolic health.

2. What geopolitical factors could impact mineral salt supply chains?
Regions with abundant natural brine sources, such as China and Middle Eastern countries, are significant suppliers. Political instability, trade restrictions, or environmental regulations could disrupt supply and affect prices.

3. Are there environmentally sustainable production options for these compounds?
Yes, advances in fermentation technology for amino acids and eco-friendly mineral extraction methods offer sustainable alternatives, appealing to environmentally conscious stakeholders and regulatory agencies.

4. What are the main challenges faced by companies in this market?
Key challenges include regulatory compliance, raw material price fluctuations, supply chain disruptions, and maintaining technological innovation to stay competitive.

5. How might bioengineering influence the future of amino acids?
Genetic engineering and synthetic biology could enable more efficient, cost-effective production of amino acids, broadening application scope and improving profit margins.


Sources:
[1] Market Research Future, “Amino Acids Market Analysis,” 2022.
[2] Grand View Research, “Mineral Salts Market Trends,” 2022.
[3] Transparency Market Research, “Global Pharmaceutical Salts Market,” 2021.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.